AONN+ Discussion Board

AONN+ presents a new space for you to discuss all things navigation and oncology care! Network and gain support through this new community platform.

Rules and Regulations

Survey on 14-Day Rule Impact on Biomarker Testing

  • Candice Roth
  • Candice Roth's Avatar Topic Author
  • Banned
  • Banned
  • Posts: 14

Survey on 14-Day Rule Impact on Biomarker Testing was created by Candice Roth

Posted 8 months 2 weeks ago #299
Timely biomarker testing is essential for accurate cancer diagnoses and effective treatment. We are evaluating how the Medicare 14-Day Rule affects timely testing, treatment decisions, and billing processes.LUNGevity, the Academy of Oncology Nurse & Patient Navigators (AONN+), the Association of Cancer Care Centers (ACCC), and the Advanced Practitioner Society for Hematology and Oncology (APSHO) are conducting a nationwide survey to assess its impact on patient care across all cancers, as well as its billing implications for hospitals and health systems.We are seeking input from healthcare providers, billing professionals, and practice managers. Your participation will help drive advocacy efforts to improve access to precision medicine.

 [url] sw2.decipherinc.com/survey/selfserve/1ce2/250403?list=2 [/url]The survey will be available for a limited time. As a thank you, the first 300 complete survey responses have an option to receive a $20 Starbucks gift card.For questions, please contact Nikki Martin at nmartin@lungevity.org.Thank you for advancing biomarker testing and cancer care!
by Candice Roth

Please Log in or Create an account to join the conversation.

  • Kristi M Griffith
  • Kristi M Griffith's Avatar
  • User
  • User
  • Posts: 6

Replied by Kristi M Griffith on topic Survey on 14-Day Rule Impact on Biomarker Testing

Posted 8 months 3 hours ago #303
Hello friends, 

Timely biomarker testing is essential for accurate cancer diagnoses and effective treatment. 
 
We are evaluating how the Medicare 14-Day Rule affects timely testing, treatment decisions, and billing processes.LUNGevity, the Academy of Oncology Nurse & Patient Navigators (AONN+), the Association of Cancer Care Centers (ACCC), and the Advanced Practitioner Society for Hematology and Oncology (APSHO) are conducting a nationwide survey to assess its impact on patient care across all cancers, as well as its billing implications for hospitals and health systems.

We are seeking input from healthcare providers, billing professionals, and practice managers. YOUR participation will help drive advocacy efforts to improve access to precision medicine. Survey Link: sw2.decipherinc.com/survey/selfserve/1ce2/250403?list=2 

The survey will be available for a limited time. As a thank you, the first 300 complete survey responses have an option to receive a $20 Starbucks gift card. For questions, please contact Nikki Martin at nmartin@lungevity.org. Thank you for advancing biomarker testing and cancer care!

Please complete the survey and claim your $20 Starbuck gift card NOW!! Limited time left.

Kristi M. Griffith, MSN, RN, CHPN, ONN-CG
Survivorship Navigator
KGriffith@LUNGevity.org
Direct: 312.639.4529
www.LUNGevity.org  
by Kristi M Griffith

Please Log in or Create an account to join the conversation.